Influence of Patient-Reported Treatment Satisfaction on Psychological Health and Quality of Life Among Patients Receiving Divya-Swasari-Coronil-Kit Against COVID-19: Findings from a Cross-Sectional “SATISFACTION COVID” Survey

Figures & data

Figure 1 SATISFACTION COVID study conceptual model. Each path is identified by the hypothesis with which it is associated. Treatment satisfaction: TSQM (Treatment Satisfaction Questionnaire for Medication), psychological health: DASS-21 (Depression, Anxiety and Stress Scale:21), and health-related Quality of Life: EQ-5D-5L (EuroQol–5 Dimension−5 level).

Table 1 Demographic Characteristics and Frequencies at the Baseline for the Study Sample (N=367)

Socio-Demographic Details (SATISFACTION COVID)
Variables		Number of Patients (%)
Gender	Male	260 (70.8)
	Female	107 (29.2)
	Others	None
Age	18–28	118 (32.2)
	29–38	150 (40.9)
	39–48	67 (18.3)
	49–58	25 (6.8)
	59–68	7 (1.9)
Marital Status	Single	91 (24.8)
	Married	276 (75.2)
	Widowed/Separated/Divorced	None
Modified Kuppuswamy Scale
Education	Post-Graduation	194 (52.9)
	Graduate	144 (39.2)
	Intermediate	12 (3.3)
	High School	7 (1.9)
	Middle School	2 (0.5)
	Primary School	5 (1.4)
	Illiterate	3 (0.8)
Occupation	Professional	222 (60.5)
	Semi-professional	70 (19.1)
	Clerical/shop/farm	15 (4.1)
	Skilled	3 (0.8)
	Semi-skilled	10 (2.7)
	Unskilled	5 (1.4)
	Unemployed	42 (11.4)
Monthly Income	≥ ₹31,507	105 (28.6)
	₹15,754-₹31,506	124 (33.8)
	₹11,817-₹15,754	22 (6.0)
	₹7878-₹11,816	2 (0.5)
	₹4727-₹7877	65 (17.7)
	₹1590-₹4726	5 (1.4)
	≤₹1589	44 (12.0)
Socio-economic class	Upper class	117 (31.9)
	Upper middle	39 (10.6)
	Lower middle	172 (46.9)
	Upper lower	36 (9.8)
	Lower	3 (0.8)

Figure 2 Purpose of prophylactic ayurvedic treatment regime. (A) Patient experienced physical symptoms for which preventive remedy of Divya-Swasari-Coronil-Kit was administered. (B) Socio-medical reasons for taking prophylaxis treatment of Divya-Swasari-Coronil-Kit in the study participants.

Table 2 Correlation Matrix for the TSQM, HR-QoL, PH, and Demographic Variables

Predictor		M±SD	1	2	3	4	5	6	7	8	9	10	11
1	Age	33.61±9.47	1
2	Gender	0.29±0.45	−0.157**	1
3	Physical Symptoms	1.12±1.69	0.228**	−0.059	1
4	Modified Kuppuswamy Scale	21.85±3.94	0.292**	−0.124*	0.113*	1
5	Depression	7.40±3.89	−0.017	−0.005	0.457**	0.071	1
6	Anxiety	8.24±4.26	−0.073	0.032	0.468**	0.062	0.811**	1
7	Stress	7.57±4.04	−0.027	0.048	0.422**	0.104*	0.800**	0.757**	1
8	Effectiveness	88.49±7.41	0.064	0.010	0.029	0.117*	0.013	−0.033	0.021	1
9	Convenience	91.47±10.58	0.047	−0.070	0.038	0.295**	−0.075	−0.085	0.067	0.410**	1
10	Global Satisfaction	83.86±8.57	0.014	−0.034	0.207**	0.141**	−0.118*	−0.113*	−0.106*	0.412**	0.702**	1
11	HR-QoL	0.95±0.48	−0.109*	0.023	−0.638**	−0.024	−0.547**	−0.533**	−0.509**	0.643**	0.551**	0.590**	1

Notes: *Correlation is significant at p<0.05 level (2-tailed); **correlation is significant at p<0.01 level (2-tailed). Bold data represents the statistically significant outcome value of correlation.

Abbreviation: M±SD, mean±standard deviation.

Table 3 Multiple Regression Analysis with Treatment Satisfaction from Medication as the Dependent Variable

Predictor	Global Satisfaction		Effectiveness		Convenience
	Coefficient β	SE	Coefficient β	SE	Coefficient β	SE
Age	0.05	0.071	0.18*	0.72	0.02	0.06
Gender	0.45	0.31	0.76	0.33	−0.99	0.17
Marital Status	0.76*	0.56	0.90**	0.59	−0.68*	0.40
Socio-Economic Class	0.32**	0.09	0.14	0.09	0.55**	0.08
Depression	0.13	0.01	−0.40	0.62	0.13	0.55
Anxiety	−0.21	0.481	−0.33	0.48	0.29	0.43
Stress	−0.14	0.53	−0.12	0.51	−0.21	0.45
Physical Symptoms	0.83*	0.47	0.80**	0.48	0.86*	0.42
HR-QoL	0.88	0.45	0.907	0.59	0.31	0.45
Adjusted R^2	0.284		0.224		0.228
F	47.36***		31.8***		56.34***

Notes: *Significant at p<0.05 level, **significant at p<0.01, level ***significant at p<0.001 level.

Abbreviations: SE, standard error; HR-QoL, health-related quality of life.